For the quarter ending 2026-03-31, MDBH had -$3,014,000 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Deferred costs of initial public offering | - | - | 0 | 0 |
| Acquisition of non-controlling interest | - | 0 | - | - |
| Net cash provided by financing activities | - | 0 | 0 | 0 |
| Accretion of investments at amortized cost (u.s treasury bills) | - | 0 | 0 | 0 |
| Income recognized from warrants received | - | 1,889,000 | 0 | 0 |
| Clearing deposits | - | 984,719 | 3 | -722,722 |
| Accretion of deferred grant reimbursement | - | - | 0 | 0 |
| Impairment of investment securities | - | 0 | - | - |
| Portion of loss from equity investment | - | - | -1,068,539 | -1,979,744 |
| Deferred revenue | - | 0 | 0 | 0 |
| Depreciation of property and equipment | - | - | 5,655 | 11,311 |
| Deferred costs related to revenue | - | - | -9,521 | -4,329 |
| Warrants received as part of investment banking deal | - | - | 0 | -990,426 |
| Grants receivable | - | 0 | 0 | 0 |
| Unrealized loss on investment securities, net | - | 2,184,483 | 1,225,329 | -3,655,812 |
| Payables to non-customers | - | 41 | 0 | -41 |
| Gain related to dilution events | - | 41,137 | 19,863 | - |
| Gain on deconsolidation | - | 0 | - | - |
| Net loss | -6,736,000 | -1,757,799 | -4,656,811 | -14,851,390 |
| Unrealized loss on investment securities, held by the licensed broker dealer | -3,044,000 | 14,000 | - | - |
| Unrealized loss on investment securities, not held by the licensed broker dealer | -116,000 | - | - | - |
| Stock-based compensation | 2,381,000 | 2,705,933 | 2,504,577 | 6,561,490 |
| Effect of deconsolidation of subsidiary | - | 0 | - | - |
| Depreciation of property and equipment | 5,000 | 22,000 | - | - |
| Dilution of deferred grant reimbursement | - | 0 | - | - |
| Deferred costs related to revenue | 5,000 | -13,000 | - | - |
| Warrants received as part of investment banking deal | -1,020,000 | 0 | - | - |
| Portion of loss from equity investment | 1,108,000 | 4,282,000 | - | - |
| Loss related to dilution events | -96,000 | - | - | - |
| Change in rou asset | 25,000 | 24,635 | 23,948 | 46,417 |
| Change in lease liability | -28,000 | -26,918 | -26,314 | -49,768 |
| Related party payables | - | - | -9,382 | 8,295 |
| Related party receivables | 14,000 | -214,395 | -92,582 | 255,977 |
| Accounts receivable | 61,000 | -119,652 | -8,804 | 228,456 |
| Prepaid expenses and other current assets | -37,000 | 173,830 | -124,951 | -103,879 |
| Accounts payable | 81,000 | 49,509 | 44,083 | -35,592 |
| Payables to customers | -1,937,000 | 1,354,845 | 150,453 | -88,298 |
| Related party payables | -1,000 | -22,000 | - | - |
| Accrued expenses | -36,000 | 35,100 | -12,956 | -144 |
| Net cash used in operating activities | -2,945,000 | -360,362 | -1,917,545 | -3,406,093 |
| Purchases of property and equipment | - | - | 25,677 | 0 |
| Purchases of investment securities, at amortized cost (u.s. treasury bills) | - | 0 | 0 | 0 |
| Proceeds from payments and maturities of investment securities, at amortized cost (u.s. treasury bills) | - | 0 | 0 | 0 |
| Accretion of equity investments | - | 0 | - | - |
| Deferred grant reimbursement | - | 0 | 0 | 0 |
| Purchases of property and equipment | 69,000 | 49,000 | - | - |
| Net cash used in investing activities | -69,000 | -23,323 | -25,677 | 0 |
| Net increase (decrease) in cash and cash equivalents | - | -383,685 | - | - |
| Net decrease in cash, cash equivalents, and restricted cash | -3,014,000 | -383,685 | -1,943,222 | -3,406,093 |
| Cash, cash equivalents, and restricted cash - beginning of period | 15,548,000 | 15,931,918 | 21,281,233 | - |
| Cash, cash equivalents, and restricted cash - end of period | 12,534,000 | 15,548,000 | 15,931,918 | - |
MDB Capital Holdings, LLC (MDBH)
MDB Capital Holdings, LLC (MDBH)